BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 28786791)

  • 1. Tuberculosis and latent tuberculous infection screening of migrants in Europe: comparative analysis of policies, surveillance systems and results.
    Kunst H; Burman M; Arnesen TM; Fiebig L; Hergens MP; Kalkouni O; Klinkenberg E; Orcau À; Soini H; Sotgiu G; Zenner D; de Vries G
    Int J Tuberc Lung Dis; 2017 Aug; 21(8):840-851. PubMed ID: 28786791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Country-specific approaches to latent tuberculosis screening targeting migrants in EU/EEA* countries: A survey of national experts, September 2019 to February 2020.
    Margineanu I; Rustage K; Noori T; Zenner D; Greenaway C; Pareek M; Akkerman O; Hayward S; Friedland JS; Goletti D; Stienstra Y; Hargreaves S;
    Euro Surveill; 2022 Mar; 27(12):. PubMed ID: 35332865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. European policies in the management of tuberculosis among migrants.
    D'Ambrosio L; Centis R; Dara M; Solovic I; Sulis G; Zumla A; Migliori GB
    Int J Infect Dis; 2017 Mar; 56():85-89. PubMed ID: 27836793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effectiveness and cost-effectiveness of screening for latent tuberculosis among migrants in the EU/EEA: a systematic review.
    Greenaway C; Pareek M; Abou Chakra CN; Walji M; Makarenko I; Alabdulkarim B; Hogan C; McConnell T; Scarfo B; Christensen R; Tran A; Rowbotham N; van der Werf MJ; Noori T; Pottie K; Matteelli A; Zenner D; Morton RL
    Euro Surveill; 2018 Apr; 23(14):. PubMed ID: 29637889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for tuberculosis in migrants and visitors from high-incidence settings: present and future perspectives.
    Dobler CC; Fox GJ; Douglas P; Viney KA; Ahmad Khan F; Temesgen Z; Marais BJ
    Eur Respir J; 2018 Jul; 52(1):. PubMed ID: 29794133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberculosis care among refugees arriving in Europe: a ERS/WHO Europe Region survey of current practices.
    Dara M; Solovic I; Sotgiu G; D'Ambrosio L; Centis R; Tran R; Goletti D; Duarte R; Aliberti S; de Benedictis FM; Bothamley G; Schaberg T; Abubakar I; Teixeira V; Ward B; Gratziou C; Migliori GB
    Eur Respir J; 2016 Sep; 48(3):808-17. PubMed ID: 27492827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How effective are approaches to migrant screening for infectious diseases in Europe? A systematic review.
    Seedat F; Hargreaves S; Nellums LB; Ouyang J; Brown M; Friedland JS
    Lancet Infect Dis; 2018 Sep; 18(9):e259-e271. PubMed ID: 29778396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Migrant tuberculosis screening in the EU/EEA: yield, coverage and limitations.
    Klinkenberg E; Manissero D; Semenza JC; Verver S
    Eur Respir J; 2009 Nov; 34(5):1180-9. PubMed ID: 19880618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuberculosis in migrants in low-incidence countries: epidemiology and intervention entry points.
    Lönnroth K; Mor Z; Erkens C; Bruchfeld J; Nathavitharana RR; van der Werf MJ; Lange C
    Int J Tuberc Lung Dis; 2017 Jun; 21(6):624-637. PubMed ID: 28482956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into culturally appropriate latent tuberculosis infection (LTBI) screening in NSW: perspectives of Indian and Pakistani migrants.
    Hall J; Kabir TM; Shih P; Degeling C
    Aust N Z J Public Health; 2020 Oct; 44(5):353-359. PubMed ID: 32776658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extrapulmonary tuberculosis among migrants in Europe, 1995 to 2017.
    Hayward SE; Rustage K; Nellums LB; van der Werf MJ; Noori T; Boccia D; Friedland JS; Hargreaves S
    Clin Microbiol Infect; 2021 Sep; 27(9):1347.e1-1347.e7. PubMed ID: 33352301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness and cost-effectiveness of screening migrants for active tuberculosis and latent tuberculous infection.
    Zenner D; Hafezi H; Potter J; Capone S; Matteelli A
    Int J Tuberc Lung Dis; 2017 Sep; 21(9):965-976. PubMed ID: 28826445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Building a European database to gather multi-country evidence on active and latent TB screening for migrants.
    Öhd JN; Lönnroth K; Abubakar I; Aldridge RW; Erkens C; Jonsson J; Marchese V; Matteelli A; Menezes D; Zenner D; Hergens MP
    Int J Infect Dis; 2019 Mar; 80S():S45-S49. PubMed ID: 30826482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effectiveness and cost-effectiveness of screening for active tuberculosis among migrants in the EU/EEA: a systematic review.
    Greenaway C; Pareek M; Abou Chakra CN; Walji M; Makarenko I; Alabdulkarim B; Hogan C; McConnell T; Scarfo B; Christensen R; Tran A; Rowbotham N; Noori T; van der Werf MJ; Pottie K; Matteelli A; Zenner D; Morton RL
    Euro Surveill; 2018 Apr; 23(14):. PubMed ID: 29637888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of tuberculosis screening for migrant children in a low-incidence country.
    Usemann J; Ledergerber M; Fink G; Ritz N
    Int J Tuberc Lung Dis; 2019 May; 23(5):579-586. PubMed ID: 31097066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A scoping review of cost-effectiveness of screening and treatment for latent tubercolosis infection in migrants from high-incidence countries.
    Zammarchi L; Casadei G; Strohmeyer M; Bartalesi F; Liendo C; Matteelli A; Bonati M; Gotuzzo E; Bartoloni A;
    BMC Health Serv Res; 2015 Sep; 15():412. PubMed ID: 26399233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for active and latent TB among migrants in France.
    Luan L; Fraisse P; Cordel H; Charlois C; Méchaï F; Ibanez G; Hargreaves S; Mechain M; Vignier N
    Int J Tuberc Lung Dis; 2021 Nov; 25(11):903-910. PubMed ID: 34686232
    [No Abstract]   [Full Text] [Related]  

  • 18. Screening for active and latent tuberculosis among asylum seekers in Italy: A retrospective cohort analysis.
    Pontarelli A; Marchese V; Scolari C; Capone S; El-Hamad I; Donato F; Moioli R; Girardi E; Cirillo DM; Castelli F; Matteelli A
    Travel Med Infect Dis; 2019; 27():39-45. PubMed ID: 30347248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling the Cost-Effectiveness of Latent Tuberculosis Screening and Treatment Strategies in Recent Migrants to a Low-Incidence Setting.
    Dale KD; Abayawardana MJ; McBryde ES; Trauer JM; Carvalho N
    Am J Epidemiol; 2022 Jan; 191(2):255-270. PubMed ID: 34017976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies to reach and motivate migrant communities at high risk for TB to participate in a latent tuberculosis infection screening program: a community-engaged, mixed methods study among Eritreans.
    Spruijt I; Haile DT; Erkens C; van den Hof S; Goosen S; Ten Kate A; Teshome H; Karels M; Koenders M; Suurmond J
    BMC Public Health; 2020 Mar; 20(1):315. PubMed ID: 32164637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.